Join to View Full Profile
3401 Civic Center BlvdChildrens Hospital of Philadelphia NeurologyPhiladelphia, PA 19104
Phone+1 215-590-1719
Fax+1 215-590-1771
Dr. Lynch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2021 - 2027
PA State Medical License 1990 - 2026
MD State Medical License 2022 - 2024
VA State Medical License 2021 - 2024
NC State Medical License 2020 - 2022
OH State Medical License 1990 - 2014
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Start of enrollment: 2007 Dec 01
- Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients Start of enrollment: 2008 Jul 01
- Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Automated Deep Learning-based Segmentation of the Dentate Nucleus Using Quantitative Susceptibility Mapping MRI.Diogo H Shiraishi, Susmita Saha, Isaac M Adanyeguh, Sirio Cocozza, Louise A Corben
Radiology. Artificial Intelligence. 2025-11-01 - 1 citationsAntisense oligonucleotide therapy for patients with Friedreich's ataxia carrying the c.165+5G>C splicing mutation.Pouiré Yameogo, Selina Aguilar, Thazha P Prakash, Frank Rigo, David R Lynch
Molecular Therapy. Nucleic Acids. 2025-09-09 - Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies.Brent L Fogel, Thomas Klopstock, David R Lynch, Francesca Maltecca, Mayank Verma
Annals of Neurology. 2025-09-01
Press Mentions
New Genetic Discovery Could Change How Friedreich's Ataxia Is DiagnosedJuly 20th, 2025- Vigil Neuroscience Announces First Subject Enrolled in a Natural History Study of Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)September 15th, 2021
- Reata Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides an Update on Clinical Development ProgramsAugust 9th, 2021
- Join now to see all
Grant Support
- Analytical validation of frataxin proteoforms in blood as biomarkers of Friedreich's ataxiaUNIVERSITY OF PENNSYLVANIA2020–2025
- Nicotinic-Glutamatergic Interactions In Axonal DevelopmentNational Institute Of Neurological Disorders And Stroke2011
- Regulation Of NMDA Receptors In Excitotoxicity By Calpain And FYNNational Institute Of Neurological Disorders And Stroke2008–2011
- Defining The Epitope In Antinmda Receptor EncephalitisNational Institute Of Neurological Disorders And Stroke2009–2010
- Regulation Of NMDA Receptors In Excitotoxicity By Calpain And FYNNational Institute Of Neurological Disorders And Stroke2007
- Calpain Mediated Cleavage Of NR2 In ExcitotoxicityNational Institute Of Neurological Disorders And Stroke2004–2006
- Calpain Mediated Cleavage Of NR2 In ExcitotoxicityNational Institute Of Neurological Disorders And Stroke2003
- NMDA Receptors, Protein Kinase C, And ExcitotoxicityNational Institute Of Neurological Disorders And Stroke1999–2002
- PCP And The NMDA ReceptorNational Institute On Drug Abuse1996–1999
- Biochemical Approach To NMDA Receptors &ExcitotoxicityNational Institute Of Neurological Disorders And Stroke1995–1999
- NMDA Receptors--Biochemical Definition And Pharmacological CharacterizationEunice Kennedy Shriver National Institute Of Child Health &Human Development1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
